131 related articles for article (PubMed ID: 12767068)
21. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
[TBL] [Abstract][Full Text] [Related]
22. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
[TBL] [Abstract][Full Text] [Related]
23. Induction of T cell dependent acquired immunity in syngeneic mice by the combined expression of interleukin-4 and granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.
Tasaki K; Gunji Y; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Kouzu T; Sakiyama S; Tagawa M
Anticancer Res; 1998; 18(3A):1453-6. PubMed ID: 9673355
[TBL] [Abstract][Full Text] [Related]
24. IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response.
Adris S; Klein S; Jasnis M; Chuluyan E; Ledda M; Bravo A; Carbone C; Chernajovsky Y; Podhajcer O
Gene Ther; 1999 Oct; 6(10):1705-12. PubMed ID: 10516719
[TBL] [Abstract][Full Text] [Related]
25. Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma.
Hu P; Hu HD; Chen M; Peng ML; Tang L; Tang KF; Matsui M; Belladonna ML; Yoshimoto T; Zhang DZ; Xiang R; Ren H
Mol Immunol; 2009 May; 46(8-9):1654-62. PubMed ID: 19299021
[TBL] [Abstract][Full Text] [Related]
26. Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response.
Gunji Y; Tagawa M; Matsubara H; Takenaga K; Shimada H; Kondo F; Suzuki T; Nakajima K; Aoki T; Asano T; Ochiai T; Isono K; Kageyama H; Nakamura Y; Sakiyama S
Int J Cancer; 1996 Mar; 66(1):135-9. PubMed ID: 8608957
[TBL] [Abstract][Full Text] [Related]
27. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
Sun Y; Peng D; Lecanda J; Schmitz V; Barajas M; Qian C; Prieto J
Gene Ther; 2000 Sep; 7(17):1467-76. PubMed ID: 11001366
[TBL] [Abstract][Full Text] [Related]
28. Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts.
Nagakawa H; Shimozato O; Yu L; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
Scand J Immunol; 2004 Nov; 60(5):449-54. PubMed ID: 15541036
[TBL] [Abstract][Full Text] [Related]
29. Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.
Adris S; Chuluyan E; Bravo A; Berenstein M; Klein S; Jasnis M; Carbone C; Chernajovsky Y; Podhajcer OL
Cancer Res; 2000 Dec; 60(23):6696-703. PubMed ID: 11118055
[TBL] [Abstract][Full Text] [Related]
30. Effects on apoptosis and cell cycle arrest contribute to the antitumor responses of interleukin-27 mediated by retrovirus in human pancreatic carcinoma cells.
Liu L; Meng J; Zhang C; Duan Y; Zhao L; Wang S; Shan B
Oncol Rep; 2012 May; 27(5):1497-503. PubMed ID: 22293948
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD40 ligand in CD40-positive murine tumors activates transcription of the interleukin-23 subunit genes and produces antitumor responses.
Wada A; Tada Y; Shimozato O; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
Anticancer Res; 2004; 24(5A):2713-6. PubMed ID: 15517876
[TBL] [Abstract][Full Text] [Related]
32. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
[TBL] [Abstract][Full Text] [Related]
33. Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12.
Caminschi I; Venetsanakos E; Leong CC; Garlepp MJ; Robinson BW; Scott B
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):347-56. PubMed ID: 10460752
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 gene.
Gunji Y; Tasaki K; Tagawa M; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Sakiyama S
Cancer Gene Ther; 1998; 5(6):339-43. PubMed ID: 9917087
[TBL] [Abstract][Full Text] [Related]
35. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
Søndergaard H; Galsgaard ED; Bartholomaeussen M; Straten PT; Odum N; Skak K
J Immunother; 2010 Apr; 33(3):236-49. PubMed ID: 20445344
[TBL] [Abstract][Full Text] [Related]
36. Combination of IL-12 and IL-18 of electro-gene therapy synergistically inhibits tumor growth.
Tamura T; Nishi T; Goto T; Takeshima H; Ushio Y; Sakata T
Anticancer Res; 2003; 23(2B):1173-9. PubMed ID: 12820368
[TBL] [Abstract][Full Text] [Related]
37. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.
Hanari N; Matsubara H; Hoshino I; Akutsu Y; Nishimori T; Murakami K; Sakata H; Miyazawa Y; Ochiai T
Anticancer Res; 2007; 27(4B):2305-10. PubMed ID: 17695518
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effects and immunoregulation mechanisms of IL-23 gene in mouse mammary cancer mediated by retrovirus.
Liu L; Shan B; Feng Y
Cell Immunol; 2009; 258(2):181-7. PubMed ID: 19500780
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
Komita H; Homma S; Saotome H; Zeniya M; Ohno T; Toda G
J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
[TBL] [Abstract][Full Text] [Related]
40. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity.
Fakhrai H; Shawler DL; Gjerset R; Naviaux RK; Koziol J; Royston I; Sobol RE
Hum Gene Ther; 1995 May; 6(5):591-601. PubMed ID: 7578396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
